Trial Profile
Effect on Efficacy, Safety and Quality of Life by Long-Term Treatment of Long-Acting Risperidone Microspheres in Patients With Schizophrenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2013
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen
- 14 May 2009 New trial record